IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
15.06.2023 13:14:50
|
IDEXX Labs Launch First Veterinary Diagnostic Test To Detect Kidney Injury In Cats And Dogs
(RTTNews) - Pet healthcare company IDEXX Laboratories, Inc. (IDXX) announced Thursday the launch of the first veterinary diagnostic test for detecting kidney injury in cats and dogs.
According to a recent IDEXX survey, as many as one-third of kidney cases seen by veterinarians are related to kidney injury, and a diagnosis can be challenging due to subtle or nonspecific signs.
The IDEXX Cystatin B Test will be included in test panels assessing renal health, uncovering new clinical insights for an estimated two million patient visits annually.
These tests will be run at IDEXX Reference Laboratories starting later this year in the U.S. and Canada, with plans to introduce the test in Europe in 2024.
IDEXX SDMA testing provides veterinarians with unmatched insights into kidney function, and the IDEXX Cystatin B Test will enhance their view into kidney health by detecting injury and providing additional clarity when a change in kidney function may not be apparent.
Together, the IDEXX Cystatin B and IDEXX SDMA tests offer a comprehensive view of the kidneys by uncovering structural injury and impaired kidney function.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
12.05.25 |
NASDAQ Composite Index-Papier IDEXX Laboratories-Aktie: So viel Gewinn hätte ein IDEXX Laboratories-Investment von vor 5 Jahren eingefahren (finanzen.at) | |
07.05.25 |
Zuversicht in New York: Schlussendlich Pluszeichen im NASDAQ 100 (finanzen.at) | |
07.05.25 |
Zurückhaltung in New York: So entwickelt sich der NASDAQ 100 nachmittags (finanzen.at) | |
05.05.25 |
NASDAQ Composite Index-Titel IDEXX Laboratories-Aktie: So viel Gewinn hätte ein Investment in IDEXX Laboratories von vor 3 Jahren eingefahren (finanzen.at) | |
01.05.25 |
Gewinne in New York: S&P 500 legt schlussendlich zu (finanzen.at) | |
01.05.25 |
NASDAQ-Handel: NASDAQ 100 beendet den Donnerstagshandel im Plus (finanzen.at) | |
01.05.25 |
Pluszeichen in New York: S&P 500 zeigt sich am Donnerstagnachmittag fester (finanzen.at) | |
01.05.25 |
NASDAQ-Handel: Das macht der NASDAQ Composite am Nachmittag (finanzen.at) |
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 463,00 | 1,18% |
|